Komori
Disclosure8283PALTAC CORPORATIONTrading & Wholesale

Notice of the Delisting of Our Shares

Following the approval of a demand for the sale of our shares by 株式会社メディパルホールディングス, our shares will meet the Tokyo Stock Exchange's delisting criteria and will be delisted on 10 August 2026.

Worth reading
67In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Decision and Details

The Company's Board of Directors

Delisting of our shares

Decision15 July 2026
Implementation10 August 2026 (scheduled delisting date)
Going forwardOur shares will be delisted as of 10 August 2026.
Reason

Our shares became subject to the Tokyo Stock Exchange's delisting criteria as a result of the resolution to approve the demand for the sale of our common shares by 株式会社メディパルホールディングス, our controlling shareholder (parent company).

Decision and Details
ItemDetails
Matter CoveredDelisting of our shares
Decision-Making BodyThe Company's Board of Directors
Decision Date15 July 2026
Implementation Date10 August 2026 (scheduled delisting date)
ReasonOur shares became subject to the Tokyo Stock Exchange's delisting criteria as a result of the resolution to approve the demand for the sale of our common shares by 株式会社メディパルホールディングス, our controlling shareholder (parent company).
Governing RuleTokyo Stock Exchange, Inc.'s delisting criteria
Related previous disclosures“Notice Regarding the Decision by 株式会社メディパルホールディングス to Make a Demand for the Sale of Our Shares, Approval of the Demand for the Sale of Shares, and the Delisting of Our Shares,” dated 15 July 2026
Future plansOur shares will be delisted as of 10 August 2026.
Items this document does not state (4)
Period CoveredAmountQuantity / scaleImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Our Board of Directors resolved to approve the demand for the sale of our common shares by 株式会社メディパルホールディングス, our controlling shareholder.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Delisting of Our Shares | PALTAC CORPORATION (8283) timely disclosure | Komori